Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP641850.RAArxwMq2DHCVTUhIGuR-wC5CLP73qMEbuoIR8uKy0ufg130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641850.RAArxwMq2DHCVTUhIGuR-wC5CLP73qMEbuoIR8uKy0ufg130_provenance.
• NP506897.RApG4oYCZNh3bmmzAMLbDOrjtYy3ELzZJV-eWSRKfHkaA130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506897.RApG4oYCZNh3bmmzAMLbDOrjtYy3ELzZJV-eWSRKfHkaA130_provenance.
• NP915703.RAUcs4UXSYHlOsz4g-mCAZHZMows8_BeqOUZOTmVuFr2k130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915703.RAUcs4UXSYHlOsz4g-mCAZHZMows8_BeqOUZOTmVuFr2k130_provenance.
• NP780287.RAYgbG9H2NnwAEaoYTJaeXGQjD71jHKr6qSXAO-unLii0130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780287.RAYgbG9H2NnwAEaoYTJaeXGQjD71jHKr6qSXAO-unLii0130_provenance.
• NP276599.RA2U2jXLcHk4GbTo_NfL_JRxMk_-ZI1C_3UzZIGBnkzu0130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276599.RA2U2jXLcHk4GbTo_NfL_JRxMk_-ZI1C_3UzZIGBnkzu0130_provenance.
• NP812378.RA8uAm5HuQh6IwsBHzbuH2mKzRY-tY8aKXZBwoOn7gr-s130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812378.RA8uAm5HuQh6IwsBHzbuH2mKzRY-tY8aKXZBwoOn7gr-s130_provenance.
• NP664198.RAReHUr-lex8gMRiAoPjE4ggTiAPFjVEmMoJ9Kd5rT8j0130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664198.RAReHUr-lex8gMRiAoPjE4ggTiAPFjVEmMoJ9Kd5rT8j0130_provenance.
• NP664207.RAYI9tLaeUIKzu2OOga1HNpl-Kc0WDtoh4vneMXivZDgM130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664207.RAYI9tLaeUIKzu2OOga1HNpl-Kc0WDtoh4vneMXivZDgM130_provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP862976.RAqrn8szLhDk3Bvc5qBPQKEkp-tC9t4BNxCF5KLOubX0E130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862976.RAqrn8szLhDk3Bvc5qBPQKEkp-tC9t4BNxCF5KLOubX0E130_provenance.
• NP1005879.RAUtSy52NOZFFmdsqaHTO2J3bIqYY8zUj3yrHExsVLGKE130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005879.RAUtSy52NOZFFmdsqaHTO2J3bIqYY8zUj3yrHExsVLGKE130_provenance.
• NP755186.RAAYIR2cXUaw2-ivpsBZ_qjqJHtsb0W3p4aKfZBmP1V3g130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755186.RAAYIR2cXUaw2-ivpsBZ_qjqJHtsb0W3p4aKfZBmP1V3g130_provenance.
• NP755153.RAjddBYM0RtKpFlxw3AjZyjnCxJBP13iOpdTdzpaX3Cmk130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755153.RAjddBYM0RtKpFlxw3AjZyjnCxJBP13iOpdTdzpaX3Cmk130_provenance.
• NP53604.RAqBRKv2mDVdJX6l-_DjuZlW3dJTV8IZQnDtb1rLqY1dI130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53604.RAqBRKv2mDVdJX6l-_DjuZlW3dJTV8IZQnDtb1rLqY1dI130_provenance.
• NP1005877.RAnhSQQn-cEzFJ0lwK_olXhZVgEn82MKWdR9GY-xQjMBw130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005877.RAnhSQQn-cEzFJ0lwK_olXhZVgEn82MKWdR9GY-xQjMBw130_provenance.
• NP1005883.RAnUamft9FkEB5MgusnaArLGobGzY6HexfcA2vEVzQQwQ130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005883.RAnUamft9FkEB5MgusnaArLGobGzY6HexfcA2vEVzQQwQ130_provenance.
• NP862885.RAE0Ng0v-3JwkpEswkU8jF2XiHA96LiFwxM2B_-qfU4ZI130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862885.RAE0Ng0v-3JwkpEswkU8jF2XiHA96LiFwxM2B_-qfU4ZI130_provenance.
• NP1005881.RAM-_J2x4Zj8KdODhWXrcF7qE-kXLil1Xrvcfn12FeZWQ130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005881.RAM-_J2x4Zj8KdODhWXrcF7qE-kXLil1Xrvcfn12FeZWQ130_provenance.
• NP1005875.RA-FTl4M1HqWracpUqXmyeUYqdx3UoJ8VFGYKMmVqQQYc130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005875.RA-FTl4M1HqWracpUqXmyeUYqdx3UoJ8VFGYKMmVqQQYc130_provenance.
• NP1005880.RA716oYoN81ZNFNtrOoAKgBP_JedDpE_cd2AL3mLgmudE130_assertion description "[Several other genetic regions including variants of CHEK2 (22q12), TP53BP1 (15q15) and RAD52 (12p13) have been demonstrated to influence lung cancer risk in candidate- or pathway-based analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005880.RA716oYoN81ZNFNtrOoAKgBP_JedDpE_cd2AL3mLgmudE130_provenance.